author-photo

Rachel Riley

Harvard University

3

Papers

90

Citations

Citation Trend

Filter By

Papers (3) Sort By

Journal Conference Others

Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus-Unrelated Head and Neck Cancer: A Multicenter, Phase 2 Trial

2020 medRxiv
Show All
- Source
- Cite
- Save
Citations (1)
Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus-Unrelated Head and Neck Cancer: A Multicenter, Phase 2 Trial.

2020 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (44)
Targeting EZH2 enhances antigen presentation, antitumor immunity and circumvents anti-PD-1 resistance in head and neck cancers

2019 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (45)